8-10
Jul
2026
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
M32

Grand Life Sciences(Liaoning)Co., Ltd

About Grand Life Sciences(Liaoning)Co., Ltd

Grand Life Sciences (Liaoning) Co., Ltd., a wholly-owned subsidiary of Grand Life Sciences Group, is a full-value-chain pharmaceutical enterprise integrating R&D, production, and marketing. The company focuses on the fields of hemostasis, anesthesia and analgesia, and wound management, dedicated to providing original biologics, complex high-end formulation products, and medical devices made from biodegradable materials. The company operates an independent pharmaceutical sales division and maintains a dedicated R&D center. It possesses a comprehensive modern production base, a dedicated active pharmaceutical ingredient (API) manufacturing facility, and overseas API supply bases. Looking ahead...

Meet us at

  • CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • Country/Region:
    China
  • On CPHI since:
    2026
Contact info
  • No. 18-1, East Nanping Road, Hunnan New District, Shenyang City Liaoning Province, Shenyang, Liaoning, China